“The monoclonal antibodies rituximab, ocrelizumab, ofatumumab (Kesimpta), and ublituximab (Briumvi) provide outstanding ...

Patients with rheumatoid arthritis (RA) have a higher risk of osteoporotic fractures if they have elevated adipokines, according to a recent report. 1 However, the investigators behind the study, ...

Combining genetic features with clinical data improved the performance of a pulmonary fibrosis prediction score for people with rheumatoid arthritis. A new combined risk score that incorporates ...

Patients with age-related macular degeneration (AMD) or polypoidal choroidal vasculopathy (PCV) who had not been treated previously were found to have better control of pigment epithelial detachment ...

Patients with chronic spontaneous urticaria (CSU) experienced improved quality of life and sleep when symptoms were mitigated ...

Hearn Jay Cho, MD, PhD, chief medical officer at the Multiple Myeloma Research Foundation, shared insights on what end points ...

In the KEYNOTE-B96 trial ( NCT05116189 ), weekly paclitaxel with bevacizumab and pembrolizumab (Keytruda; Merck) demonstrated ...

Among adults surveyed, 27.8% (95% CI, 25.7-29.8) received all telemental health care, 21.5% (95% CI, 19.8-23.1) received ...

Sibeprenlimab gains accelerated approval from the FDA for IgA nephropathy, showing significant proteinuria reduction and ...

Eleanor Perfetto, PhD, explores how most favored nation policy relates to broader drug pricing and cost-effectiveness debates ...

Careful consideration of individual patient factors and thorough consultations are key for pharmacists to maximize their impact on cancer care access and adherence, according to Ryan Haumschild, ...

While limited data suggest loncastuximab tesirine plus rituximab may be active in the third line, larger cohorts and ...